Color Doppler myocardial imaging is a new technique that has been developed specifically to allow color Doppler imaging of myocardial wall motion rather than blood pool imaging. Such a technique has the potential to interrogate velocities, accelerations, and Doppler signal strength within the myocardial wall. Moreover, the concomitant enhancement of the myocardial Doppler signal after an intravenous injection of a transpulmonary echocardiographic contrast agent could permit the noninvasive assessment of regional myocardial perfusion. Thus this new imaging modality could be a valuable adjunct to the ultrasound assessment of myocardial ischemia.

Animals↗

PubMedDate not supplied

Assessment of skeletal muscle ventricle function using tissue velocity imaging.

BACKGROUND AND AIMS: Skeletal muscle ventricles (SMVs) are a potential power source for circulatory assistance. Noninvasive assessment of SMVs is desirable in long-term studies of SMV function. This study evaluated whether tissue velocity imaging (TVI) indices of function correlate with invasive measurements of output and pressure generation and examined the potential of TVI to provide information about SMV geometry and wall contraction characteristics. METHODS: SMVs were constructed in six sheep. After electrical conditioning, SMVs were connected to a mock circulation and stimulated with supramaximal 30-Hz and 50-Hz bursts to contract 35 times/min. The SMVs were tested over a range of preloads, and afterload was adjusted to simulate systemic (80 mmHg) and right ventricular (30 mmHg) loading conditions. Stroke volume and pressure were measured invasively, and stroke work was calculated. TVI was used to measure velocities in two opposing SMV walls, providing a simple wall motion score (WMS). This was evaluated against stroke volume, stroke work, and pressure development. RESULTS: 50-Hz stimulation frequency and high preload optimized SMV performance. Optimal SMV performance indices (mean at 50 Hz) were as follows: (a) right ventricular loading conditions (preload 30 mmHg), stroke volume 17.6 mL (SEM 3.2), peak pressure over afterload 44.2 mmHg (10.9), stroke work 0.05 J (0.02); (b) systemic loading conditions (preload 60 mmHg), stroke volume 10.1 mL (3.2), peak pressure over afterload 58 mmHg (14.6), stroke work 0.08 J (0.03). With low preloads, geometric anomalies were noted in the SMVs using TVI. Collapse of the SMVs and dyskinesis were observed, which normalized with higher preloads. Persistent dyskinesis was noted in one SMV and was associated with poor performance. Correlations (at optimal loading and stimulation settings) were as follows: systemic loading conditions, stroke volume versus WMS, 0.92 (p = 0.026); peak pressure versus WMS 0.89 (p = 0.045); stroke work versus WMS, r = 0.91 (p = 0.046). Right ventricular loading conditions were as follows: stroke volume versus WMS, 0.63 (p = 0.25); peak pressure versus WMS, 0.66 (p = 0.22); stroke work versus WMS, 0.45 (p = 0.39). CONCLUSION: Under systemic loading conditions, TVI indices of SMV wall motion mirror invasive indices of performance, suggesting that TVI may be a useful tool for long-term noninvasive monitoring of SMV function.

Animals↗

PubMedDate not supplied

Renal calcification: a complication of dexamethasone therapy in preterm infants with bronchopulmonary dysplasia.

We have previously reported a case study in which renal calcification formation may have been a complication of dexamethasone exposure in an infant with bronchopulmonary dsyplasia. To determine whether dexamethasone is associated with renal calcification formation, we conducted a prospective, nonrandomized study of 36 infants < 30 weeks' gestation and weighing < 1250 gm treated with dexamethasone because of bronchopulmonary dysplasia and compared them with a group not receiving dexamethasone. We identified seven infants in the dexamethasone group (n = 19) but no infant in the comparison group (n = 17) with renal calcifications at 2 months of age (p = 0.008). The urinary calcium excretion tended to be increased (15.5 +/- 16.6 vs 6.9 +/- 6.7 mg/kg/day ¿p = 0.05¿) and the calcium/creatinine ratio was significantly greater in the dexamethasone group (1.2 +/- 1.0 vs 0.6 +/- 0.4 ¿p = 0.02¿). Infants who received dexamethasone were significantly smaller 819.1 +/- 141.1 vs 954.6 +/- 141 gm ¿p = 0.008¿), were younger (26.2 +/- 1.7 vs 27.7 +/- 1.2 weeks ¿p = 0.004¿), received ventilator support longer (33.3 +/- 14.7 vs 12.1 +/- 14.7 days ¿p = 0.0001¿), and required more days of supplemental oxygen (54.3 +/- 9.7 vs 36.4 +/- 23.8 days ¿p = 0.009¿). We conclude that smaller, younger, and sicker infants are at the highest risk for the development of renal calcifications and that dexamethasone may be associated with increased urinary calcium excretion, which contributes to renal calcification formation.

Bronchopulmonary Dysplasia↗